Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

COMPARISON OF THE ANTIEMETIC EFFECTIVENESS BETWEEN GRANISETRON AND DEXAMETHASONE WITH ONDANSETRON AND DEXAMETHASONE IN ACUTE-PHASE CHEMOTHERAPY PATIENTS

Folia Medica Indonesiana · Vol. 52 No. 3 (2017) · pp. 185–185

DOI
10.20473/fmi.v52i3.5450
ISSN
2355-8393, 2599-056X
Published
2017-08-14
Publisher
Airlangga University
Language
en
License
creativecommons.org/licenses/by-nc-sa/4.0/

Abstract

Nausea and vomiting may occur in patients receiving chemotherapy, a condition referred to as chemotherapy-induced nausea and vomiting. The provision of combined dexamethasone and ondansetron or granisetron is the therapeutic management of acute phase nausea and vomiting in cytostatics with a high risk of nausea and vomiting. Granisetron has been known to have better pharmacokinetics and pharmacodynamics compared to ondansetron, so it is possible to have nausea and vomiting suppressing effect higher than that of ondansetron. This study aimed to compare antiemetic effectiveness of granisetron and dexamethasone with ondansetron and dexamethasone in acute-phase chemotherapy patients. This study was conducted in patients who received the combination of cisplatin-paclitaxel and cisplatin-fluorouracil, double-blind, with samples comprised new head and neck surgical oncology patients. Measurement of nausea and vomiting during the acute phase of chemotherapy was conducted using Index of Nausea, Vomiting, and Retching (INVR). Observation of nausea and vomiting in the patients was done during the first 12 hours after administration of cisplatin and interviews were conducted on h 12. Results showed that there was no difference in the effectiveness of nausea and vomiting suppression in the administration of granisetron and dexamethasone compared to ondanstron and dexamethasone in acute phase chemotherapy patients (p = 0.076).

Keywords

Collaboration network of the authors

27 authors · 65 co-authorship links · 12 across different organisations

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Universitas Airlangga
  • State University of Makassar
  • University of Brawijaya
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Mahardian RahmadiUniversitas Airlangga2
Junaidi KhotibUniversitas Airlangga2
Eddy RahardjoUniversitas Airlangga2
Dewi Wara ShintaUniversitas Airlangga2
Yulistiani YulistianiUniversitas Airlangga2
Andi Bulqiah NurState University of Makassar1
Moch YusufUniversitas Airlangga1
YulistianiUniversitas Airlangga1
Wulida Nuril FajriyahState University of Makassar1
Zam Zami JauhariUniversitas Airlangga1
Diyah WahyuniUniversitas Airlangga1
Ramadi Satryo WicaksonoAffiliation unknown1
Abdul Kadir JaelaniAffiliation unknown1
Vini Siane TanaemUniversitas Airlangga1
Anak Agung Ngurah Putra Riana PrasetyaUniversitas Airlangga1
Bayu Dharma ShantiAffiliation unknown1
Mida PurwiningtyasUniversitas Airlangga1
Bayu Dharma SantiAffiliation unknown1
Sarah Puspita AtmajaUniversitas Airlangga1
Suharjono SuharjonoUniversity of Brawijaya1
Ekanita DesianiUniversitas Airlangga1
Agung Dwi Wahyu WidodoUniversitas Airlangga1
Muhammad Thariq NadhafiAffiliation unknown1
Bambang WahjuprajitnoAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">COMPARISON OF THE ANTIEMETIC EFFECTIVENESS BETWEEN GRANISETRON AND DEXAMETHASONE WITH ONDANSETRON AND DEXAMETHASONE IN ACUTE-PHASE CHEMOTHERAPY PATIENTS</dc:title><dc:creator>Ria Fitrah Arfiani</dc:creator><dc:creator>Dwi Hari Susilo</dc:creator><dc:creator>Budi Suprapti</dc:creator><dc:subject>chemotherapy-induced nausea and vomiting</dc:subject><dc:subject>antiemetic efficacy</dc:subject><dc:subject>granisetron</dc:subject><dc:subject>ondansetron</dc:subject><dc:subject>dexamethasone</dc:subject><dc:subject>cisplatin</dc:subject><dc:subject>paclitaxel</dc:subject><dc:subject>5-fluorouracil</dc:subject><dc:subject>head and neck cancer</dc:subject><dc:description xml:lang="en">Nausea and vomiting may occur in patients receiving chemotherapy, a condition referred to as chemotherapy-induced nausea and vomiting. The provision of combined dexamethasone and ondansetron or granisetron is the therapeutic management of acute phase nausea and vomiting in cytostatics with a high risk of nausea and vomiting. Granisetron has been known to have better pharmacokinetics and pharmacodynamics compared to ondansetron, so it is possible to have nausea and vomiting suppressing effect higher than that of ondansetron. This study aimed to compare antiemetic effectiveness of granisetron and dexamethasone with ondansetron and dexamethasone in acute-phase chemotherapy patients. This study was conducted in patients who received the combination of cisplatin-paclitaxel and cisplatin-fluorouracil, double-blind, with samples comprised new head and neck surgical oncology patients. Measurement of nausea and vomiting during the acute phase of chemotherapy was conducted using Index of Nausea, Vomiting, and Retching (INVR). Observation of nausea and vomiting in the patients was done during the first 12 hours after administration of cisplatin and interviews were conducted on h 12. Results showed that there was no difference in the effectiveness of nausea and vomiting suppression in the administration of granisetron and dexamethasone compared to ondanstron and dexamethasone in acute phase chemotherapy patients (p = 0.076).</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2017-08-14</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v52i3.5450</dc:identifier><dc:identifier>10.20473/fmi.v52i3.5450</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 52 No 3 (2017); 185-185</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/5450/3357</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>